TTF1 and metastatic malignant neoplasm: Although our data show a very high sensitivity (94.1%) of TTF-1 IHC for lung adenocarcinomas, it is conspicuous that its specificity (86%) is not optimal for a safe separation of pulmonary adenocarcinomas from morphologically similar metastatic cancers.